Innovative Health launches new platform to improve access to at-home healthcare services

Innovative Health Diagnostics (IHD), a FDA-certified testing lab, has announced the launch of a new platform to give patients access to at-home healthcare services.

Digital health and healthcare DTC entities – including fertility clinics, OBGYNs, primary care providers and pharmacies – can utilise IHD’s partner platform, Diagnostics as a Service (DaaS) , to offer consumers over 70 different at-home tests, from infectious disease and wellness to women’s and men’s health.

The platform aims to bridge the gap between digital health services and diagnostics and create a more complete customer experience with emphasis on fast turnaround times and actionable results provided by IHD.

“Our DaaS platform furthers our mission of providing a better experience across medication, treatment and overall understanding of personal health,” said IHD CEO and co-founder, David White.

“By offering at-home testing, digital health and healthcare entities can significantly increase access to wider customer segments, whether it be additional geographies, opening new prescriptions, or extending to new market segments.”

IHD says its new platform enables a better customer experience and outcomes, technology integration, and custom kits built specifically for the unique mix of tests required by the partner and its patients.

The California-based company’s health partners can leverage its end-to-end DaaS platform or select individual modules that fit into the brand’s existing operation, such as logistics and clinical networks.